英科医疗: 关于英科转债即将到期暨赎回的第六次提示性公告

Core Points - The company, Yingke Medical Technology Co., Ltd., has issued a convertible bond known as "Yingke Convertible Bond" with a total issuance amount of 470 million yuan [1][2] - The current conversion price for the bond into company stock is set at 3.42 yuan per share [2] - The bond is scheduled to mature on August 15, 2025, and will be redeemed at 128% of the face value, which amounts to 128 yuan per bond, including the last interest payment [2][3] Group 1: Convertible Bond Details - The "Yingke Convertible Bond" was approved by the China Securities Regulatory Commission and began trading on September 10, 2019 [1] - The bond has a face value of 100 yuan per bond, with a total of 4.7 million bonds issued [1] - Trading of the bond was suspended on June 29, 2021, but holders can still convert the bonds into shares until the end of the conversion period [2] Group 2: Redemption and Trading Suspension - The company will announce the bond's maturity and redemption details on the designated information disclosure website [3] - Investors are reminded that the bond will stop trading three days before the end of the conversion period [2]